LUND, Sweden, Sept. 28, 2020 /PRNewswire/ -- Alligator
Bioscience (Nasdaq Stockholm: ATORX) announced today the
appointment of Gayle Mills as Chief
Business Officer to lead the company's Business Development
activities. Ms. Mills will be a member of the executive management
team at Alligator Bioscience.
Gayle Mills is a renowned
business development professional with an unmatched industry
network and an extensive knowledge of the biotech and pharma
landscape. She has a successful track record of executing large
R&D collaborations and transactions and has held senior
positions with Roche Bioscience, Abgenix, Inc. and Symphogen A/S.
She joins Alligator Bioscience today, September 28, 2020.
"With Gayle's background and deep understanding of the antibody
drug development process, and her proven track record of signing
deals, it is with great excitement I welcome Gayle to Alligator and
to my executive management team", said Per Norlén, CEO at Alligator
Bioscience.
For further information, please contact:
Cecilia Hofvander, Director Investor
Relations & Communications
Phone +46 46 540 82 06
E-mail: cecilia.hofvander@alligatorbioscience.com
The information was submitted for publication, through the
agency of the contact person set out above, at 1:15 p.m. CEST
on September 28, 2020.
About Alligator Bioscience
Alligator Bioscience AB is a clinical-stage biotechnology
company developing tumor-directed immuno-oncology antibody drugs.
Alligator's pipeline includes five lead clinical and preclinical
drug candidates: Mitazalimab, ATOR-1015, ATOR-1017, ALG.APV-527
(co-developed with Aptevo Therapeutics Inc.) and AC101 (in clinical
development by Shanghai Henlius Biotech Inc.). Alligator's shares
are listed on Nasdaq Stockholm (ATORX). The Company is
headquartered in Lund, Sweden. For
more information, please visit www.alligatorbioscience.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/alligator-bioscience/r/alligator-bioscience-appoints-gayle-mills-as-chief-business-officer,c3204067
The following files are available for download:
https://mb.cision.com/Main/12681/3204067/1311694.pdf
|
Alligator Bioscience
appoints Gayle Mills as Chief Business Officer
|